Proper Name: NucliSens HIV-1 QT
Tradename: NucliSens HIV-1 QT
Manufacturer: bioMerieux, Inc.
- In conjunction with clinical presentation and other laboratory markers of disease progression for prognostic assessment of HIV-1 infected patients, and for monitoring the effects of anti-retroviral therapy by serial measurements of plasma HIV-1 RNA for pediatric and adult patients with baseline viral loads greater than 93,000 and 28,000 copies of HIV-1 viral RNA/mL respectively.
Approval Date: 11/19/2001